Literature DB >> 29879365

Bone Marrow Stromal Cells Promote Innervation of Bioengineered Teeth.

M Strub1,2,3, L Keller1,2, Y Idoux-Gillet1,2, H Lesot1, F Clauss1,2,3, N Benkirane-Jessel1,2, S Kuchler-Bopp1.   

Abstract

Transplantation of bone marrow mesenchymal stem cells (BMDCs) into a denervated side of the spinal cord was reported to be a useful option for axonal regeneration. The innervation of teeth is essential for their function and protection but does not occur spontaneously after injury. Cultured reassociations between dissociated embryonic dental mesenchymal and epithelial cells and implantation lead to a vascularized tooth organ regeneration. However, when reassociations were coimplanted with a trigeminal ganglion (TG), innervation did not occur. On the other hand, reassociations between mixed embryonic dental mesenchymal cells and bone marrow-derived cells isolated from green fluorescent protein (GFP) transgenic mice (BMDCs-GFP) (50/50) with an intact and competent dental epithelium (ED14) were innervated. In the present study, we verified the stemness of isolated BMDCs, confirmed their potential role in the innervation of bioengineered teeth, and analyzed the mechanisms by which this innervation can occur. For that purpose, reassociations between mixed embryonic dental mesenchymal cells and BMDCs-GFP with an intact and competent dental epithelium were cultured and coimplanted subcutaneously with a TG for 2 wk in ICR mice. Axons entered the dental pulp and reached the odontoblast layer. BMDCs-GFP were detected at the base of the tooth, with some being present in the pulp associated with the axons. Thus, while having a very limited contribution in tooth formation, they promoted the innervation of the bioengineered teeth. Using quantitative reverse transcription polymerase chain reaction and immunostainings, BMDCs were shown to promote innervation by 2 mechanisms: 1) via immunomodulation by reducing the number of T lymphocytes (CD3+, CD25+) in the implants and 2) by expressing neurotrophic factors such as NGF, BDNF, and NT3 for axonal growth. This strategy using autologous mesenchymal cells coming from bone marrow could be used to innervate bioengineered teeth without treatment with an immunosuppressor such as cyclosporine A (CsA), thus avoiding multiple side effects.

Entities:  

Keywords:  axons; cell differentiation; mesenchymal stromal cells; odontogenesis; tissue engineering; trigeminal ganglia

Mesh:

Substances:

Year:  2018        PMID: 29879365     DOI: 10.1177/0022034518779077

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  3 in total

Review 1.  Scaffold-based developmental tissue engineering strategies for ectodermal organ regeneration.

Authors:  N Contessi Negrini; A Angelova Volponi; C A Higgins; P T Sharpe; A D Celiz
Journal:  Mater Today Bio       Date:  2021-03-06

2.  The Role of Medicine and Technology in Shaping the Future of Oral Health.

Authors:  Namrata Nayyar; David M Ojcius; Arthur A Dugoni
Journal:  J Calif Dent Assoc       Date:  2020-03

Review 3.  Tooth Formation: Are the Hardest Tissues of Human Body Hard to Regenerate?

Authors:  Juliana Baranova; Dominik Büchner; Werner Götz; Margit Schulze; Edda Tobiasch
Journal:  Int J Mol Sci       Date:  2020-06-04       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.